Kodiak Sciences Inc (KOD) Financials
KOD Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 547.7 million | 245.2 million |
2023-06-30 | 589.7 million | 251.2 million |
2023-03-31 | 640.3 million | 247.7 million |
2022-12-31 | 666.6 million | 230.5 million |
KOD Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -33.0 million | 13.9 million |
2023-06-30 | -43.4 million | 25.8 million |
2023-03-31 | -59.5 million | 26.0 million |
2022-12-31 | -60.7 million | 25.8 million |
KOD Net Income
No data available :(
KOD Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 345.7 million | - | 83.5 million |
2023-06-30 | 378.7 million | - | 84.8 million |
2023-03-31 | 421.2 million | - | 86.8 million |
2022-12-31 | 478.9 million | - | 87.7 million |
KOD Shares Outstanding
KOD Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 226000 | 36.2 million | 18.3 million | - |
2023-06-30 | 1.5 million | 67.0 million | 17.9 million | - |
2023-03-31 | 12.2 million | 56.5 million | 18.1 million | - |
2022-12-31 | 5.6 million | 56.0 million | 18.1 million | - |
KOD Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | - | 7.0 million |
2023-06-30 | - | 6.7 million |
2023-03-31 | - | 5.7 million |
2022-12-31 | - | 3.3 million |
KOD
Price: $3.77
52 week price:
Earnings Per Share: -5.19 USD
P/E Ratio: -0.78
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 76500
Market Capitalization: 234.0 million